Jack Phillips - Aug 13, 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Executive Officer, Director
Signature: /s/ David Patience, attorney-in-fact
Stock symbol: AXDX
Transactions as of: Aug 13, 2023
Transactions value $: -$5,107
Form type: 4
Date filed: 8/15/2023, 07:22 PM
Previous filing: Jul 17, 2023
Next filing: Sep 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+1.72K	+3.15%	$0.00	56.4K	Aug 13, 2023	Direct	F1
transaction	AXDX	Common Stock	Sale	-$5.11K	-751	-1.33%	$6.80	55.6K	Aug 14, 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-1.72K	-20%	$0.00	6.89K	Aug 13, 2023	Common Stock	1.72K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 20,659 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.